Results 131 to 140 of about 57,330 (350)

Binder’s Syndrome [PDF]

open access: yes, 2011
Binder's Syndrome also known as Maxillo-Nasal Dysplasia is a developmental disorder primarily affecting the anterior part of the maxilla and nasal complex (nose and jaw). It is a rare disorder and the causes are unclear.
Babu, SG   +3 more
core  

Unique skin manifestations of COVID-19: Is drug eruption specific to COVID-19? [PDF]

open access: hybrid, 2020
Takashi SAKAIDA   +4 more
openalex   +1 more source

Drug Allergy Risk Stratification in Children With Immediate or Delayed Urticaria During Antibiotic Treatment

open access: yes
Clinical &Experimental Allergy, EarlyView.
Francesca Mori   +8 more
wiley   +1 more source

Primary Cutaneous B‐Cell Lymphomas: An Updated Portrait of Classification, Biology, and Clinical Management

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT Primary cutaneous B‐cell lymphomas (CBCL) represent a clinically and biologically heterogeneous group of extranodal non‐Hodgkin lymphomas confined to the skin at the time of diagnosis. They account for approximately 25% of all primary cutaneous lymphomas and are subclassified into distinct entities according to the World Health Organization ...
A. Bernardelli   +5 more
wiley   +1 more source

Drug-induced anti-Ro positive subacute cutaneous lupus in a man treated with olmesartan [PDF]

open access: yes, 2019
A 66-year-old man presented to the outpatient dermatology clinic with a chief complaint of a pruritic rash on his upper trunk and proximal upper extremities, which had been present for three weeks.
Farsi, Maheera   +4 more
core  

Fixed Drug Eruption due to Fluconazole: Not so uncommon Now-a-days

open access: gold, 2014
Ranjita Santra   +2 more
openalex   +1 more source

A randomized, double‐blind, placebo‐controlled, multicenter study to evaluate the efficacy and safety of adjunctive cenobamate in Asian patients with focal seizures

open access: yesEpilepsia, EarlyView.
A randomized, double‐blind, placebo‐controlled, multicenter study to evaluate the efficacy and safety of adjunctive cenobamate in Asian patients with focal seizures. Abstract Objectives This randomized, double‐blind, placebo‐controlled study (NCT04557085), conducted in China, Japan, and the Republic of Korea, evaluated the efficacy and safety of ...
Sang Kun Lee   +20 more
wiley   +1 more source

Early response rates with adjunctive cenobamate in uncontrolled focal seizures: Prospective analysis of a randomized, double‐blind, placebo‐controlled study in a multinational Asian population

open access: yesEpilepsia, EarlyView.
Graphical representation of article highlights, including early response rates with adjunctive cenobamate. Abstract Objective To examine early responses to cenobamate therapy using prospective data from a dose–response study in Asian patients with focal seizures (YKP3089C035, C035) that employed a titration regimen starting at 12.5 mg/day.
Kensuke Kawai   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy